Clinical Trials Sponsored by Aleris Obesity

Total 567 results

Aleris Obesity

Completed

Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study

Weight Loss | Morbid Obesity

Sweden
Aleris Obesity
Lund University

Unknown

Effects of Long Biliopancreatic Limb Versus Long Alimentary Limb in Superobesity, a Randomized Study (BMI>50)

Severe Obesity

Sweden
Aleris Eye

Recruiting

Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods

Cataract

Sweden
Aleris Hospital

Active, not recruiting

Non-randomized Prospective Comparison Between SASI Bipartition and RYGB

Postoperative Complications | Metabolic Syndrome | Obesity, Morbid | Bariatric Surgery Candidate

Norway
Aleris Helse

Completed

Perioperative Hypothermia Hypothermia in Ambulatory Surgery

Perioperative/Postoperative Complications

Norway
Aleris Helse
Novartis

Completed

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Central Retinal Vein Occlusion | Macular Edema

Norway
Aeris Therapeutics

Terminated

A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

Lung Diseases | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease(COPD)

Israel
Aeris Therapeutics

Terminated

Post Market Registry Study of the AeriSeal System

Pulmonary Emphysema

Germany, Israel
Aeris Therapeutics

Terminated

A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema

Emphysema | Chronic Pulmonary Obstructive Disease

Germany, Israel, Austria, France
Aeris Therapeutics

Completed

AeriSeal System for Lung Volume Reduction

Lung Diseases | Emphysema | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease (COPD)

Israel, Austria, France, Germany
Aeris Therapeutics

Completed

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Pulmonary Emphysema

United States
Aeris Therapeutics

Completed

A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema

Advanced Emphysema

Germany
Aeris Therapeutics

Terminated

Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Netherlands
Aeris Therapeutics

Terminated

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Israel
Aeris Therapeutics

Completed

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Pulmonary Emphysema

United States
Aderis Pharmaceuticals

Completed

Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation

Atrial Fibrillation

United States
Karolinska Institutet
Aleris Gastromottagningen City

Not yet recruiting

Effect of a Low- Fermentable-Oligo-Di- Monosaccharides and Polyols Diet Group Intervention on IBS Symptoms and Fatigue (FODMAPS)

Irritable Bowel Syndrome
Stemform
Aleris-Hamlet Hospitaler København

Completed

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

Breast Hypoplasia and Facial Ageing

Denmark
Aeris Therapeutics

Terminated

Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE) (ASPIRE)

Pulmonary Emphysema

United States, Spain, France, Israel, Netherlands, Greece, Italy
Aeris Therapeutics

Completed

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Chronic Obstructive Pulmonary Disease | Pulmonary Emphysema

United States
Aeris Therapeutics

Completed

AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema

Lung Diseases | Pulmonary Emphysema | COPD

Israel
Aeris Therapeutics

Terminated

Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema (CV+/-)

Pulmonary Emphysema

Germany, Israel
Aeris Therapeutics

Withdrawn

Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema

Emphysema | Chronic Obstructive Pulmonary Disease (COPD)
Aeris Therapeutics

Completed

Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study

Homogeneous Emphysema

United States
Aeris Therapeutics

Completed

Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Chronic Obstructive Pulmonary Disease | Pulmonary Emphysema

Israel
Aeris Therapeutics

Withdrawn

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

Advanced Upper Lobe Predominant Emphysema
Aeris Therapeutics

Completed

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

Pulmonary Emphysema

United States
St. Olavs Hospital
Aleris Helse

Completed

Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery

Bleeding | Surgical Wound

Norway
The Miriam Hospital
The Obesity Society

Unknown

The Effects of Mindsets on the Brain's Response to Food Cues (MINDSETS)

Obesity

United States
Anergis

Completed

Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

Birch Pollen Allergy

Sweden, France, Lithuania, Denmark, Latvia, Poland, Switzerland
Anergis

Terminated

Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen (AN003)

Allergy | Allergic Rhinitis

Switzerland
Mayo Clinic
The Obesity Society

Completed

Exendin-9,39 and Satiety After Bariatric Surgery

Obesity

United States
Alexis FERRE

Recruiting

Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register. (COPDregister)

COPD Exacerbation

France
Alice Højer Christensen

Completed

The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis

Ulcerative Colitis

Denmark
Anergis

Completed

Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen

Allergic Rhinitis

Switzerland
Pennington Biomedical Research Center
The Obesity Society

Completed

Does Meal Timing Affect Energy Expenditure (GRAZING)

Meal Timing

United States
Anergis

Completed

ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen (ATIBAR)

Allergic Rhinitis

Denmark, Finland, Germany, Lithuania, Norway, Poland, Slovakia, Sweden
Anergis

Completed

Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

Allergic Rhinitis | Rhinoconjunctivitis

France, Sweden, Lithuania, Denmark, Latvia, Poland, Switzerland
The Miriam Hospital
The Obesity Society

Recruiting

Improving the Experience of Exercise Among Individuals With Internalized Weight Bias Using Acceptance-based Strategies

Overweight and Obesity

United States
British Obesity and Metabolic Surgery Society

Completed

National Introduction of One Anastomosis Gastric Bypass in the UK National Bariatric Surgery Registry

Obesity
Virginia Commonwealth University
Obesity Treatment Foundation

Completed

Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet

Obesity | Fatty Liver | Ketogenic Dieting

United States
University of Victoria
Childhood Obesity Foundation

Unknown

Family Healthy Living Early Intervention Program (EIP)

Obesity | Nutrition Disorders | Body Weight | Child Behavior | Health Behavior | Child Obesity

Canada
Temple University
The Obesity Treatment Foundation

Completed

Smart Technology for Weight Loss and Metabolic Health

Obesity | Overweight | Weight Loss | Prediabetes | Lifestyle

United States
The Miriam Hospital
The Obesity Society

Completed

Improving Behavioral Weight Loss Via Electronic Handheld Device

Obesity

United States
Valerio Therapeutics

Recruiting

A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

Breast Cancer | Prostate Cancer | Advanced or Metastatic Solid Tumors | Recurrent Ovarian Cancer

United States
Alumis Inc

Recruiting

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus (LUMUS)

SLE

United States, Argentina, Bulgaria, Colombia, Georgia, India, Mexico, Peru, Philippines, Poland, Spain, United Kingdom, Croatia, Denmark, Germany, Hungary, Korea, Republic of, Romania, Taiwan, Chile
Algenis SpA

Completed

Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study

Back Pain | Acute Pain

Chile
Abbott
Almedis

Completed

IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice (PRESTO)

Headache Disorders, Primary | Tension-Type Headache | Migraine Without Aura | Migraine With Aura

Kazakhstan, Ukraine
Axetis AG

Unknown

Axetis Inert Coronary Stent System First In Man Clinical Investigation (AXETIS FIM)

Native Coronary Artery Stenosis

Netherlands
Stemform
Rigshospitalet, Denmark; Aleris-Hamlet Hospitaler København

Active, not recruiting

Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections

Augmentation | Reconstruction

Denmark

Clinical Trials Sponsored by Aleris Obesity

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations